Avançar para navegação principal
Avançar para pesquisar
Avançar para conteúdo principal
Ordenar por
Medicine and Dentistry
Human Immunodeficiency Virus
75%
Gastrostomy
52%
Global Disease Burden
51%
Diseases
41%
Drug Resistance
39%
Percutaneous Endoscopic Gastrostomy
26%
Enteric Feeding
25%
Prevalence
23%
Polyethylene Glycol
19%
Systematic Review
18%
Infection
17%
Fibrosis
16%
Life Expectancy
16%
Transferrin
15%
Mortality Rate
14%
Malignant Neoplasm
14%
Body Mass Index
13%
Resistance Mutation
12%
Health Care Cost
12%
Health Care
12%
Observational Study
12%
Head and Neck Cancer
11%
Genetic Variability
11%
Electron Microscopy
10%
COVID-19
10%
Disability Adjusted Life Years
10%
Nonnucleoside Reverse Transcriptase Inhibitor
10%
Maturity Onset Diabetes of the Young
10%
Intestinal Failure
10%
Public Health
9%
Human Immunodeficiency Virus 1
9%
Plummer-Vinson Syndrome
9%
Microscopy
9%
Periodontitis
9%
Cross Sectional Study
9%
Intensive Care Unit
9%
Antiretroviral Therapy
9%
Reverse-Transcriptase Inhibitor
8%
Periodontal Disease
8%
Nutritional Support
8%
Upper Gastrointestinal Bleeding
8%
Human Immunodeficiency Virus 2
8%
Nutritional Status
8%
Mental Capacity
8%
Integrase
8%
Randomized Controlled Trial
8%
Nutrition Assessment
7%
Health System
7%
Industrial Noise
7%
Behavioral Change
7%
Nutrition
7%
Transmission Electron Microscopy
7%
Diabetes Mellitus
7%
Morphology
7%
Bone Turnover
7%
Fibromyalgia
7%
Cluster Randomized Trial
7%
In Vitro
6%
Arm
6%
Scanning Electron Microscopy
6%
Endoscopy
6%
Retrospective Study
6%
Diarrhea
6%
Refeeding Syndrome
6%
Respiratory Tract Infection
5%
Antiinfective Agent
5%
Probiotics
5%
HIV/AIDS
5%
Short Bowel Syndrome
5%
Gastroenterology
5%
Stomach Lesion
5%
Low and Middle Income Countries
5%
Next Generation Sequencing
5%
Anti-Inflammatory Drug
5%
Non Communicable Disease
5%
Meta-Analysis
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Antibiotics
5%
Student T Test
5%
Fistula
5%
Nutritional Intervention
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
83%
Drug Resistance
42%
Diseases
35%
Global Disease Burden
29%
Prevalence
22%
Infection
20%
Transferrin
19%
Antiinfective Agent
19%
Polyethylene Glycol
18%
Antimicrobial Agent
17%
Fibrosis
14%
Nonnucleoside Reverse Transcriptase Inhibitor
13%
Pharmacokinetics
13%
Olanzapine
13%
Wistar Rat
13%
RNA Directed DNA Polymerase Inhibitor
12%
Head and Neck Cancer
12%
Anti-Human Immunodeficiency Virus
12%
Bioequivalence
12%
Drug Release
12%
Integrase
12%
Dysphagia
11%
Diabetes Mellitus
11%
Community Pharmacy
10%
Randomized Controlled Trial
10%
Human Immunodeficiency Virus 1
9%
Non Insulin Dependent Diabetes Mellitus
9%
Nanoparticle
9%
Antibiotics
9%
Wound
8%
Human Immunodeficiency Virus 2
8%
Dental Caries
8%
Dosage Forms
8%
Observational Study
8%
Cytotoxicity
7%
Proteinase
7%
Lactam
7%
Efavirenz
7%
Dendrimer
7%
Adhesive Agent
7%
Wound Healing
7%
Rilpivirine
7%
Integrase Inhibitor
7%
Dolutegravir
6%
Hepatitis B Virus
6%
Staphylococcus Aureus
6%
Cohort Study
6%
Koji
6%
Antioxidant
6%
Hepatitis C
6%
Biocompatibility
6%
Scanning Electron Microscopy
6%
Table Salt
6%
Trace Element
6%
Side Effect
5%
Proteinase Inhibitor
5%
Antioxidant Capacity
5%
Antimicrobial Resistance
5%
Clinical Trial
5%
Plasma Protein
5%
Comorbidity
5%
Human Immunodeficiency Virus Fusion Inhibitor
5%
Serum Albumin
5%
Mycobacterium Tuberculosis
5%
Protein Calorie Malnutrition
5%
Microparticle
5%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
99%
Human Immunodeficiency Virus 2
33%
Viral Load
30%
Drug Resistance
27%
Genetic Variability
20%
Blood Plasma
19%
Virus
18%
Cladistics
17%
Dynamics
17%
Neutralizing Antibody
16%
Prevalence
16%
Antibody Response
13%
Glycoprotein
12%
Foot
12%
Antimicrobial Resistance
10%
Antibodies
10%
CD4
9%
Klebsiella pneumoniae
9%
Biofilm
9%
T-Helper Cell
9%
Peptides
8%
Candida
8%
Viremia
8%
Integrase
8%
Phylogeny
7%
Reverse Transcriptase
7%
Antimicrobial Activity
7%
Mycobacterium Tuberculosis
7%
Viral Replication
6%
Infectious Agent
6%
Staphylococcus Aureus
6%
Cytokine
6%
Microorganism
6%
Antimicrobial Agent
6%
CXCR4
6%
HIV/AIDS
5%
Cytotoxicity
5%
Minimum Inhibitory Concentration
5%
Urinary Tract
5%
Population Structure
5%
Binding Antibody
5%
Epitope
5%
Evolution
5%